Spectrum Asset Management (California)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Hold
0
-$10.8K 104
2024
Q3
Hold
0
96
2024
Q2
Hold
0
93
2024
Q1
Hold
0
99

Other funds holding PFE

Spectrum Asset Management (California)'s PFE Position: Q2 2026 in Review

Spectrum Asset Management (California) increased its Pfizer (PFE) stake by 1.5% in Q2 2026, buying an estimated $7.53K and bringing the position to 18,885 shares worth $455K. The position accounts for 0.13% of the portfolio, ranked #86.

Spectrum Asset Management (California) first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.22M in Q3 2018. 1,698 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Spectrum Asset Management (California) held 18,885 shares of Pfizer worth $455K as of Q2 2026.
  • Spectrum Asset Management (California) bought 288 Pfizer shares in Q2 2026, an estimated $7.53K.
  • Pfizer made up 0.13% of Spectrum Asset Management (California)'s portfolio in Q2 2026, its #86 holding.
  • Spectrum Asset Management (California) first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
  • Spectrum Asset Management (California)'s Pfizer position peaked at $2.22M in Q3 2018.
  • 1,698 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Spectrum Asset Management (California)'s 13F filing for Q2 2026, filed 3 Aug 2026.